BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 359922)

  • 1. A vaccine from ICRC bacilli against M. leprae infection in mouse foot-pad.
    Bhide MB; Pradhan KS; Bapat CV
    Lepr India; 1978 Jul; 50(3):334-44. PubMed ID: 359922
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth of the ICRC bacilli in the foot-pad of mice.
    Bapat CV; Modak MS
    Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
    Bapat CV
    Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with DNA of the Mycobacterium tuberculosis 85B antigen protects mouse foot pad against infection with M. leprae.
    Roche PW; Neupane KD; Failbus SS; Kamath A; Britton WJ
    Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2):93-8. PubMed ID: 11757171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
    Kale VP; Bapat CV
    Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of severe combined immunodeficient mice to Mycobacterium leprae.
    Ishaque M; Sticht-Groh V; Togola D
    Microbios; 1996; 88(354):19-26. PubMed ID: 9121376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mouse food pad model for detection of sub clinical leprosy.
    Lahiri R; Randhawa B; Franken KL; Duthie MS; Spencer JS; Geluk A; Krahenbuhl JL
    Lepr Rev; 2011 Dec; 82(4):432-44. PubMed ID: 22439282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of tolerance induced by ICRC bacilli against Mycobacterium leprae in mice.
    Jeevan A; Bapat CV; Deo MG
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):437-45. PubMed ID: 3528346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mouse foot-pad technique for cultivation of Mycobacterium leprae.
    Levy L; Ji B
    Lepr Rev; 2006 Mar; 77(1):5-24. PubMed ID: 16715686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contemporary relevance of the mouse foot pad model for cultivating M. leprae.
    Katoch VM
    Lepr Rev; 2009 Jun; 80(2):120-3. PubMed ID: 19743615
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 17. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum.
    Krahenbuhl JL; Welch TM; Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of animal models for selection of a candidate vaccine for leprosy.
    Sengupta U
    Indian J Lepr; 1991; 63(2):153-8. PubMed ID: 1783785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.